Brian K. Halak, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 29,642 shares at $5.00 ($143K) on 2013-01-30, disclosed to the SEC on 2013-02-01.
Scheduled sale ($143k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 11,105 | $56K | 38.9% |
| 2 | $4.71 | 18,537 | $87K | 61.1% |
| Total | $4.82 avg | 29,642 | $143K | 100% |
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |